Enliven Therapeutics, Inc. <ELVN.O>: Baird Assumes Coverage With Outperform Rating; Target Price $75
ELVN•Related News
Global Markets-Asian shares rise, dollar slips as markets pare Fed rate risks
SPY•
BioMarin Pharmaceutical Inc. <BMRN.O>: Piper Sandler raises target price to $88 from $82
BMRN•
Gold edges higher on softer dollar as rate-hike expectations ease
GLD•
Slater & Gordon files shareholder class action against James Hardie over FY26 guidance disclosures
JHX•
Vietnam aviation body says passenger plane returned to Munich after tail strike, tyre-pressure warnings
BA•